STOCK TITAN
  1. Home
  2. Sec-filings
  3. UVE
  4. [Form 4] UNIVERSAL INSURANCE HOLDINGS, INC. Insider Trading Activity

Universal Insurance (NYSE: UVE) exec sells stock but receives new RSU award

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

UNIVERSAL INSURANCE HOLDINGS, INC. director and CIO & CAO Kimberly D. Campos reported mixed insider activity. On March 3, 2026, she sold 1,710 shares of common stock in an open-market transaction at $35.375 per share, leaving 7,422 shares of common stock held directly.

On March 2, 2026, she also received a grant of 2,063 restricted stock units, each representing one future share of common stock subject to vesting. These RSUs are scheduled to vest in three equal-time installments: 688 shares on March 2, 2027, 688 shares on March 2, 2028, and 687 shares on March 2, 2029, assuming continued employment through each vesting date.

Positive

  • None.

Negative

  • None.
Insider Campos Kimberly D
Role CIO & CAO
Sold 1,710 shs ($60K)
Type Security Shares Price Value
Sale Common Stock 1,710 $35.375 $60K
Grant/Award Restricted Stock Units 2,063 $0.00 --
Holdings After Transaction: Common Stock — 7,422 shares (Direct); Restricted Stock Units — 2,063 shares (Direct)
Footnotes (1)
  1. Each RSU represents the right to receive one share of the Issuer's Common Stock, subject to vesting. These RSUs are scheduled to vest as follows, subject to continued employment by the reporting person through the applicable vesting date: (a) 688 shares vest on March 2, 2027; (b) 688 shares vest on March 2, 2028; and (c) 687 shares vest on March 2, 2029.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Campos Kimberly D
(Last) (First) (Middle)
1110 WEST COMMERCIAL BOULEVARD
SUITE 100
(Street)
FORT LAUDERDALE FL 33309
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
UNIVERSAL INSURANCE HOLDINGS, INC. [ UVE ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
CIO & CAO
3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/03/2026 S 1,710 D $35.375 7,422 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 03/02/2026 A 2,063 03/02/2027(2) 03/02/2029 Common Stock 2,063 $0 2,063 D
Explanation of Responses:
1. Each RSU represents the right to receive one share of the Issuer's Common Stock, subject to vesting.
2. These RSUs are scheduled to vest as follows, subject to continued employment by the reporting person through the applicable vesting date: (a) 688 shares vest on March 2, 2027; (b) 688 shares vest on March 2, 2028; and (c) 687 shares vest on March 2, 2029.
Remarks:
/s/ Kimberly D. Campos 03/04/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR